Rubella virus serology:detection of residual lipoprotein inhibitors of haemagglutination using sensitive indicator arboviruses.
Identifieur interne : 001517 ( Istex/Corpus ); précédent : 001516; suivant : 001518Rubella virus serology:detection of residual lipoprotein inhibitors of haemagglutination using sensitive indicator arboviruses.
Auteurs : K F ShortridgeSource :
- Journal of Clinical Pathology [ 0021-9746 ] ; 1977-05.
English descriptors
- Teeft :
- Ageing, Arbovirus, Arbovirus antibody, Assay, Fresh sera, Fresh serum, Haemagglutination, Haemagglutination inhibition, Hong kong, Immune rubella sera, Inhibitor, Inhibitory activity, Japanese encephalitis, Kaolin, Lipoprotein, Lipoprotein removal, Residual, Residual lipoprotein inhibitors, Rubella, Rubella sera, Rubella virus, Rubella virus infection, Rubella virus serology, Sera serum, Serum, Shortridge, Titrated, Titre, Virus, West nile.
Abstract
Immune and non-immune rubella sera were examined in the haemagglutination inhibition (HAI) test to evaluate the removal of lipoprotein non-specific inhibitors (NSI) of haemagglutination after kaolin and manganous chloride/heparin treatments. The sera were titrated fresh or after lipoprotein deterioration brought about by ageing the samples at 4 degrees C for various periods of time and by freezing at -20 degrees C with subsequent thawing. Deterioration was seen as altered electrophoretic mobility while the lipoproteins in treated sera were detected by indicator arboviruses whose haemagglutination is known to be strongly inhibited by the native macromolecules. After both treatments, notably manganous chloride/heparin, residual NSI activity was detected in deteriorated samples, particularly with group B arboviruses such as Japanese encephalitis and west Nile viruses but generally less so or not at all with the group A arboviruses employed. Absolutely fresh sera are considered highly desirable for rubella virus HAI assay, and it is suggested that the efficiency of lipoprotein NSI removal regardless of treatment protocol could be monitored in parallel HAI tests using carefully chosen indicator arboviruses. This could be done in conjunction with density gradient centrifugation of doubtful sera should ultracentrifuging facilities be available. The suitability of the monitoring procedure would be dependent to some extent on whether certain arboviruses are known to be endemic in a particular area.
Url:
DOI: 10.1136/jcp.30.5.409
Links to Exploration step
ISTEX:DD8C76345B1ECF4527F15355BE9C5E11C51A5454Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rubella virus serology:detection of residual lipoprotein inhibitors of haemagglutination using sensitive indicator arboviruses.</title><author wicri:is="90%"><name sortKey="Shortridge, K F" sort="Shortridge, K F" uniqKey="Shortridge K" first="K F" last="Shortridge">K F Shortridge</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:DD8C76345B1ECF4527F15355BE9C5E11C51A5454</idno><date when="1977" year="1977">1977</date><idno type="doi">10.1136/jcp.30.5.409</idno><idno type="url">https://api.istex.fr/ark:/67375/NVC-BP37HTG3-D/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001517</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001517</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Rubella virus serology:detection of residual lipoprotein inhibitors of haemagglutination using sensitive indicator arboviruses.</title><author wicri:is="90%"><name sortKey="Shortridge, K F" sort="Shortridge, K F" uniqKey="Shortridge K" first="K F" last="Shortridge">K F Shortridge</name></author></analytic><monogr></monogr><series><title level="j">Journal of Clinical Pathology</title><title level="j" type="abbrev">J Clin Pathol</title><idno type="ISSN">0021-9746</idno><idno type="eISSN">1472-4146</idno><imprint><publisher>BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><date type="published" when="1977-05">1977-05</date><biblScope unit="volume">30</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="409">409</biblScope></imprint><idno type="ISSN">0021-9746</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0021-9746</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Ageing</term><term>Arbovirus</term><term>Arbovirus antibody</term><term>Assay</term><term>Fresh sera</term><term>Fresh serum</term><term>Haemagglutination</term><term>Haemagglutination inhibition</term><term>Hong kong</term><term>Immune rubella sera</term><term>Inhibitor</term><term>Inhibitory activity</term><term>Japanese encephalitis</term><term>Kaolin</term><term>Lipoprotein</term><term>Lipoprotein removal</term><term>Residual</term><term>Residual lipoprotein inhibitors</term><term>Rubella</term><term>Rubella sera</term><term>Rubella virus</term><term>Rubella virus infection</term><term>Rubella virus serology</term><term>Sera serum</term><term>Serum</term><term>Shortridge</term><term>Titrated</term><term>Titre</term><term>Virus</term><term>West nile</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Immune and non-immune rubella sera were examined in the haemagglutination inhibition (HAI) test to evaluate the removal of lipoprotein non-specific inhibitors (NSI) of haemagglutination after kaolin and manganous chloride/heparin treatments. The sera were titrated fresh or after lipoprotein deterioration brought about by ageing the samples at 4 degrees C for various periods of time and by freezing at -20 degrees C with subsequent thawing. Deterioration was seen as altered electrophoretic mobility while the lipoproteins in treated sera were detected by indicator arboviruses whose haemagglutination is known to be strongly inhibited by the native macromolecules. After both treatments, notably manganous chloride/heparin, residual NSI activity was detected in deteriorated samples, particularly with group B arboviruses such as Japanese encephalitis and west Nile viruses but generally less so or not at all with the group A arboviruses employed. Absolutely fresh sera are considered highly desirable for rubella virus HAI assay, and it is suggested that the efficiency of lipoprotein NSI removal regardless of treatment protocol could be monitored in parallel HAI tests using carefully chosen indicator arboviruses. This could be done in conjunction with density gradient centrifugation of doubtful sera should ultracentrifuging facilities be available. The suitability of the monitoring procedure would be dependent to some extent on whether certain arboviruses are known to be endemic in a particular area.</div></front></TEI><istex><corpusName>bmj</corpusName><keywords><teeft><json:string>rubella</json:string><json:string>lipoprotein</json:string><json:string>kaolin</json:string><json:string>arbovirus</json:string><json:string>haemagglutination</json:string><json:string>shortridge</json:string><json:string>rubella virus</json:string><json:string>ageing</json:string><json:string>hong kong</json:string><json:string>titrated</json:string><json:string>inhibitory activity</json:string><json:string>inhibitor</json:string><json:string>haemagglutination inhibition</json:string><json:string>residual lipoprotein inhibitors</json:string><json:string>fresh serum</json:string><json:string>lipoprotein removal</json:string><json:string>rubella virus serology</json:string><json:string>japanese encephalitis</json:string><json:string>fresh sera</json:string><json:string>residual</json:string><json:string>assay</json:string><json:string>titre</json:string><json:string>rubella virus infection</json:string><json:string>arbovirus antibody</json:string><json:string>west nile</json:string><json:string>sera serum</json:string><json:string>rubella sera</json:string><json:string>immune rubella sera</json:string><json:string>serum</json:string><json:string>virus</json:string></teeft></keywords><author><json:item><name>K F Shortridge</name></json:item></author><arkIstex>ark:/67375/NVC-BP37HTG3-D</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>research-article</json:string></originalGenre><abstract>Immune and non-immune rubella sera were examined in the haemagglutination inhibition (HAI) test to evaluate the removal of lipoprotein non-specific inhibitors (NSI) of haemagglutination after kaolin and manganous chloride/heparin treatments. The sera were titrated fresh or after lipoprotein deterioration brought about by ageing the samples at 4 degrees C for various periods of time and by freezing at -20 degrees C with subsequent thawing. Deterioration was seen as altered electrophoretic mobility while the lipoproteins in treated sera were detected by indicator arboviruses whose haemagglutination is known to be strongly inhibited by the native macromolecules. After both treatments, notably manganous chloride/heparin, residual NSI activity was detected in deteriorated samples, particularly with group B arboviruses such as Japanese encephalitis and west Nile viruses but generally less so or not at all with the group A arboviruses employed. Absolutely fresh sera are considered highly desirable for rubella virus HAI assay, and it is suggested that the efficiency of lipoprotein NSI removal regardless of treatment protocol could be monitored in parallel HAI tests using carefully chosen indicator arboviruses. This could be done in conjunction with density gradient centrifugation of doubtful sera should ultracentrifuging facilities be available. The suitability of the monitoring procedure would be dependent to some extent on whether certain arboviruses are known to be endemic in a particular area.</abstract><qualityIndicators><score>8.574</score><pdfWordCount>3970</pdfWordCount><pdfCharCount>26684</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>8</pdfPageCount><pdfPageSize>504.96 x 680.16 pts</pdfPageSize><refBibsNative>false</refBibsNative><abstractWordCount>217</abstractWordCount><abstractCharCount>1514</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Rubella virus serology:detection of residual lipoprotein inhibitors of haemagglutination using sensitive indicator arboviruses.</title><pmid><json:string>864010</json:string></pmid><genre><json:string>research-article</json:string></genre><host><title>Journal of Clinical Pathology</title><language><json:string>unknown</json:string></language><issn><json:string>0021-9746</json:string></issn><eissn><json:string>1472-4146</json:string></eissn><volume>30</volume><issue>5</issue><pages><first>409</first></pages><genre><json:string>journal</json:string></genre></host><namedEntities><unitex><date><json:string>18S</json:string><json:string>1977-05-01</json:string><json:string>12S</json:string></date><geogName><json:string>Semliki</json:string></geogName><orgName><json:string>Virus Reference Laboratory, Central Public Health Laboratory, London</json:string><json:string>Standards Laboratory, Central Public Health Laboratory</json:string><json:string>Flow Laboratories Inc</json:string><json:string>Yale Arbovirus Research Unit, USA</json:string><json:string>American Public Health Association, New York</json:string><json:string>Difco Laboratories, Detroit</json:string><json:string>Hawksley and Sons Ltd</json:string><json:string>National Institute of Health, Japan</json:string><json:string>Department of Pathology, University of Hong Kong</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>I. Variables</json:string><json:string>Hong Kong</json:string><json:string>A. Oya</json:string><json:string>H. G. S. Rubella</json:string><json:string>Y. Hu</json:string><json:string>K. F. Shortridge</json:string><json:string>London School</json:string><json:string>H. G. S. Initial</json:string><json:string>N. J. Schmidt</json:string><json:string>P. Higgins</json:string><json:string>B. Johnson</json:string><json:string>J. Immunol</json:string><json:string>R. Shope</json:string><json:string>E. H. Lennette</json:string></persName><placeName><json:string>Nile</json:string><json:string>Calif</json:string><json:string>Hong Kong</json:string><json:string>Richmond</json:string><json:string>London</json:string><json:string>USA</json:string><json:string>England</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>Shortridge and Hu, 1974</json:string><json:string>Beaumont et al.</json:string><json:string>Beaumont et al., 1970</json:string><json:string>Shortridge and Ho, 1974</json:string><json:string>Clarke and Casals (1958)</json:string><json:string>Levy and Frederickson, 1965</json:string><json:string>Schmidt et al., 1971</json:string><json:string>Shortridge This was carried out in linear sucrose gradients and Ho, 1976</json:string><json:string>Liebhaber (1970)</json:string><json:string>Pepper, 1968</json:string><json:string>Monath et al., 1970</json:string><json:string>Haukenes, 1973</json:string><json:string>Biddle and Shortridge (1967)</json:string><json:string>Shortridge and Hu, 1976</json:string><json:string>Hatch and Lees, 1968</json:string><json:string>Shortridge and Ho, 1976</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/NVC-BP37HTG3-D</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - pathology</json:string></wos><scienceMetrix></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - General Medicine</json:string><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Pathology and Forensic Medicine</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string><json:string>4 - pathologie infectieuse</json:string></inist></categories><publicationDate>1977</publicationDate><copyrightDate>1977</copyrightDate><doi><json:string>10.1136/jcp.30.5.409</json:string></doi><id>DD8C76345B1ECF4527F15355BE9C5E11C51A5454</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/NVC-BP37HTG3-D/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/NVC-BP37HTG3-D/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/NVC-BP37HTG3-D/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Rubella virus serology:detection of residual lipoprotein inhibitors of haemagglutination using sensitive indicator arboviruses.</title><respStmt><resp>Références bibliographiques récupérées via GROBID</resp><name resp="ISTEX-API">ISTEX-API (INIST-CNRS)</name></respStmt></titleStmt><publicationStmt><authority>ISTEX</authority><publisher scheme="https://publisher-list.data.istex.fr">BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><availability><licence><p>© British Medical Journal Publishing Group</p></licence><p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-7M42M2QJ-2">bmj</p></availability><date>1977-05-01</date></publicationStmt><notesStmt><note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note><note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Rubella virus serology:detection of residual lipoprotein inhibitors of haemagglutination using sensitive indicator arboviruses.</title><author xml:id="author-0000"><persName><forename type="first">K F</forename><surname>Shortridge</surname></persName></author><idno type="istex">DD8C76345B1ECF4527F15355BE9C5E11C51A5454</idno><idno type="ark">ark:/67375/NVC-BP37HTG3-D</idno><idno type="DOI">10.1136/jcp.30.5.409</idno><idno type="href">jclinpath-30-409.pdf</idno><idno type="PMID">864010</idno><idno type="local">jclinpath;30/5/409</idno></analytic><monogr><title level="j">Journal of Clinical Pathology</title><title level="j" type="abbrev">J Clin Pathol</title><idno type="pISSN">0021-9746</idno><idno type="eISSN">1472-4146</idno><idno type="PublisherID-hwp">jclinpath</idno><idno type="PublisherID-nlm-ta">J Clin Pathol</idno><imprint><publisher>BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><date type="published" when="1977-05"></date><biblScope unit="volume">30</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="409">409</biblScope></imprint></monogr></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1977-05-01</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Immune and non-immune rubella sera were examined in the haemagglutination inhibition (HAI) test to evaluate the removal of lipoprotein non-specific inhibitors (NSI) of haemagglutination after kaolin and manganous chloride/heparin treatments. The sera were titrated fresh or after lipoprotein deterioration brought about by ageing the samples at 4 degrees C for various periods of time and by freezing at -20 degrees C with subsequent thawing. Deterioration was seen as altered electrophoretic mobility while the lipoproteins in treated sera were detected by indicator arboviruses whose haemagglutination is known to be strongly inhibited by the native macromolecules. After both treatments, notably manganous chloride/heparin, residual NSI activity was detected in deteriorated samples, particularly with group B arboviruses such as Japanese encephalitis and west Nile viruses but generally less so or not at all with the group A arboviruses employed. Absolutely fresh sera are considered highly desirable for rubella virus HAI assay, and it is suggested that the efficiency of lipoprotein NSI removal regardless of treatment protocol could be monitored in parallel HAI tests using carefully chosen indicator arboviruses. This could be done in conjunction with density gradient centrifugation of doubtful sera should ultracentrifuging facilities be available. The suitability of the monitoring procedure would be dependent to some extent on whether certain arboviruses are known to be endemic in a particular area.</p></abstract></profileDesc><revisionDesc><change when="1977-05-01">Created</change><change when="1977-05">Published</change><change xml:id="refBibs-istex" who="#ISTEX-API" when="2017-10-17">References added</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/NVC-BP37HTG3-D/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus bmj" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="no"</istex:xmlDeclaration><istex:docType PUBLIC="-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" URI="archivearticle.dtd" name="istex:docType"></istex:docType><istex:document><article article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="hwp">jclinpath</journal-id><journal-id journal-id-type="nlm-ta">J Clin Pathol</journal-id><journal-title>Journal of Clinical Pathology</journal-title><abbrev-journal-title abbrev-type="publisher">J Clin Pathol</abbrev-journal-title><issn pub-type="ppub">0021-9746</issn><issn pub-type="epub">1472-4146</issn><publisher><publisher-name>BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">864010</article-id><article-id pub-id-type="other">jclinpath;30/5/409</article-id><article-id pub-id-type="doi">10.1136/jcp.30.5.409</article-id><article-id pub-id-type="other">409</article-id><article-id pub-id-type="other">jcp.30.5.409</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Rubella virus serology:detection of residual lipoprotein inhibitors of haemagglutination using sensitive indicator arboviruses.</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Shortridge</surname><given-names>K F</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><month>5</month><year>1977</year></pub-date><pub-date pub-type="epub"><day>1</day><month>5</month><year>1977</year></pub-date><volume>30</volume><volume-id pub-id-type="other">30</volume-id><volume-id pub-id-type="other">30</volume-id><issue>5</issue><issue-id pub-id-type="other">jclinpath;30/5</issue-id><issue-id pub-id-type="other">5</issue-id><issue-id pub-id-type="other">30/5</issue-id><fpage>409</fpage><self-uri content-type="pdf" xlink:role="full-text" xlink:href="jclinpath-30-409.pdf"></self-uri><abstract><p>Immune and non-immune rubella sera were examined in the haemagglutination inhibition (HAI) test to evaluate the removal of lipoprotein non-specific inhibitors (NSI) of haemagglutination after kaolin and manganous chloride/heparin treatments. The sera were titrated fresh or after lipoprotein deterioration brought about by ageing the samples at 4 degrees C for various periods of time and by freezing at -20 degrees C with subsequent thawing. Deterioration was seen as altered electrophoretic mobility while the lipoproteins in treated sera were detected by indicator arboviruses whose haemagglutination is known to be strongly inhibited by the native macromolecules. After both treatments, notably manganous chloride/heparin, residual NSI activity was detected in deteriorated samples, particularly with group B arboviruses such as Japanese encephalitis and west Nile viruses but generally less so or not at all with the group A arboviruses employed. Absolutely fresh sera are considered highly desirable for rubella virus HAI assay, and it is suggested that the efficiency of lipoprotein NSI removal regardless of treatment protocol could be monitored in parallel HAI tests using carefully chosen indicator arboviruses. This could be done in conjunction with density gradient centrifugation of doubtful sera should ultracentrifuging facilities be available. The suitability of the monitoring procedure would be dependent to some extent on whether certain arboviruses are known to be endemic in a particular area.</p></abstract></article-meta></front></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Rubella virus serology:detection of residual lipoprotein inhibitors of haemagglutination using sensitive indicator arboviruses.</title></titleInfo><titleInfo type="alternative" lang="en" contentType="CDATA"><title>Rubella virus serology:detection of residual lipoprotein inhibitors of haemagglutination using sensitive indicator arboviruses.</title></titleInfo><name type="personal"><namePart type="given">K F</namePart><namePart type="family">Shortridge</namePart></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="research-article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre><originInfo><publisher>BMJ Publishing Group Ltd and Association of Clinical Pathologists</publisher><dateIssued encoding="w3cdtf">1977-05</dateIssued><dateCreated encoding="w3cdtf">1977-05-01</dateCreated><copyrightDate encoding="w3cdtf">1977</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><abstract lang="en">Immune and non-immune rubella sera were examined in the haemagglutination inhibition (HAI) test to evaluate the removal of lipoprotein non-specific inhibitors (NSI) of haemagglutination after kaolin and manganous chloride/heparin treatments. The sera were titrated fresh or after lipoprotein deterioration brought about by ageing the samples at 4 degrees C for various periods of time and by freezing at -20 degrees C with subsequent thawing. Deterioration was seen as altered electrophoretic mobility while the lipoproteins in treated sera were detected by indicator arboviruses whose haemagglutination is known to be strongly inhibited by the native macromolecules. After both treatments, notably manganous chloride/heparin, residual NSI activity was detected in deteriorated samples, particularly with group B arboviruses such as Japanese encephalitis and west Nile viruses but generally less so or not at all with the group A arboviruses employed. Absolutely fresh sera are considered highly desirable for rubella virus HAI assay, and it is suggested that the efficiency of lipoprotein NSI removal regardless of treatment protocol could be monitored in parallel HAI tests using carefully chosen indicator arboviruses. This could be done in conjunction with density gradient centrifugation of doubtful sera should ultracentrifuging facilities be available. The suitability of the monitoring procedure would be dependent to some extent on whether certain arboviruses are known to be endemic in a particular area.</abstract><relatedItem type="host"><titleInfo><title>Journal of Clinical Pathology</title></titleInfo><titleInfo type="abbreviated"><title>J Clin Pathol</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><identifier type="ISSN">0021-9746</identifier><identifier type="eISSN">1472-4146</identifier><identifier type="PublisherID-hwp">jclinpath</identifier><identifier type="PublisherID-nlm-ta">J Clin Pathol</identifier><part><date>1977</date><detail type="volume"><caption>vol.</caption><number>30</number></detail><detail type="issue"><caption>no.</caption><number>5</number></detail><extent unit="pages"><start>409</start></extent></part></relatedItem><identifier type="istex">DD8C76345B1ECF4527F15355BE9C5E11C51A5454</identifier><identifier type="ark">ark:/67375/NVC-BP37HTG3-D</identifier><identifier type="DOI">10.1136/jcp.30.5.409</identifier><identifier type="href">jclinpath-30-409.pdf</identifier><identifier type="PMID">864010</identifier><identifier type="local">jclinpath;30/5/409</identifier><accessCondition type="use and reproduction" contentType="copyright">© British Medical Journal Publishing Group</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-7M42M2QJ-2">bmj</recordContentSource><recordOrigin>© British Medical Journal Publishing Group</recordOrigin></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/NVC-BP37HTG3-D/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001517 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001517 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:DD8C76345B1ECF4527F15355BE9C5E11C51A5454
|texte= Rubella virus serology:detection of residual lipoprotein inhibitors of haemagglutination using sensitive indicator arboviruses.
}}
| This area was generated with Dilib version V0.6.33. |  |